Pfizer is trading -2.29% lower at Rs 4,585.75 as compared to its last closing price. Pfizer has been trading in the price range of 4,710.85 & 4,580.75. Pfizer has given -5.82% in this year & 2.93% in the last 5 days. Pfizer has TTM P/E ratio 27.45 as compared to the sector P/E of 23.40.There are 3 analysts who have initiated coverage on Pfizer. There are 2 analysts who have given it a strong buy rating & 0.00 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 189.02 Crores in its last quarter.Listed peers of Pfizer include Aurobindo Pharma (0.67%), Unichem Laboratories (-8.15%), Themis Medicare (0.24%).The Mutual Fund holding in Pfizer was at 11.71% in 31 Dec 2025. The MF holding has decreased from the last quarter. The FII holding in Pfizer was at 2.71% in 31 Dec 2025. The FII holding has increased from the last quarter.
Updated on Feb 08, 2026, 05:45 AM UTC
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma | Bullish | 1,190.40 | 0.67 | 69,109.40 | 20.15 | 2.15 | 0.33 | 5.52 |
| Unichem Laboratories | Bearish | 395.00 | -8.15 | 2,827.38 | 23.18 | 1.29 | - | 3.51 |
| Themis Medicare | Moderately Bearish | 84.22 | 0.24 | 774.01 | 31.81 | 2.35 | 0.49 | 4.62 |
| Neuland Laboratories | Bearish | 13,036.15 | -1.24 | 16,834.40 | 92.96 | 12.69 | 0.08 | 7.17 |
| Jagsonpal Pharmaceuticals | Bearish | 168.50 | -1.52 | 1,121.54 | 33.88 | 5.54 | 1.25 | 3.18 |
| Meeting Date | Purpose |
|---|---|
| 2026-02-09 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-05-19 | Audited Results & Special Dividend |
| 2025-01-31 | Quarterly Results |
Pfizer is trading at 4585.75 as on Fri Feb 06 2026 09:54:01. This is -2.29% lower as compared to its previous closing price of 4693.45.
The market capitalization of Pfizer is 20890.86 Cr as on Fri Feb 06 2026 09:54:01.
The average broker rating on Pfizer is Strong Buy. The breakup of analyst rating is given below -
The 52 wk high for Pfizer is 5878.55 whereas the 52 wk low is 3659.74
Pfizer can be analyzed on the following key metrics -
Pfizer reported a net profit of 767.60 Cr in 2025.
The Mutual Fund Shareholding was 11.71% at the end of 31 Dec 2025.
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.